Taken together, the results of in vitro cell culture and in vivo xenograft models consistently showed that NEDD4L-mediating UBE2T degradation could inhibit the progression of LUAD cells, and ultimately reduced tumor formation. The gene discussed is NEDD4L; the disease is neoplasm.